Inspire Trust Company’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.08M Buy
65,000
+7,961
+14% +$554K 0.63% 67
2025
Q4
$3.79M Buy
57,039
+8,039
+16% +$520K 0.62% 72
2025
Q3
$3.3M Buy
49,000
+9,000
+23% +$712K 0.6% 75
2025
Q2
$3.49M Buy
40,000
+5,000
+14% +$392K 0.72% 63
2025
Q1
$2.39M Buy
35,000
+8,800
+34% +$718K 0.57% 77
2024
Q4
$2.04M Buy
+26,200
New +$1.94M 0.52% 80

Other funds holding DXCM

Inspire Trust Company's DXCM Position: Q1 2026 in Review

Inspire Trust Company increased its DexCom (DXCM) stake by 14% in Q1 2026, buying an estimated $554K and bringing the position to 65,000 shares worth $4.08M. The position accounts for 0.63% of the portfolio, ranked #67.

Inspire Trust Company first reported a position in DXCM in Q4 2024 and has held it in 6 quarters since. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Inspire Trust Company held 65,000 shares of DexCom worth $4.08M as of Q1 2026.
  • Inspire Trust Company bought 7,961 DexCom shares in Q1 2026, an estimated $554K.
  • DexCom made up 0.63% of Inspire Trust Company's portfolio in Q1 2026, its #67 holding.
  • Inspire Trust Company first reported a position in DexCom in Q4 2024 and has held it in 6 quarters since.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Inspire Trust Company's 13F filing for Q1 2026, filed 12 May 2026.